Takeda Pharmaceutical Current Cash

Takeda Pharmaceutical (TAK) currently reports a current cash of $460B as of June 2026. That compares with $350B in the prior-year period — up 31.7% year over year. Use the charts on this page to explore Takeda Pharmaceutical's current cash history and peer comparisons.

Takeda Pharmaceutical's current cash increased from $350B to $460B — a 31.7% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Takeda Pharmaceutical reported $460B in current cash as of June 2026. That compares with $350B in the prior-year period — up 31.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $460B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Takeda Pharmaceutical, and consider following TAK for alerts when major investors trade the stock.

Takeda Pharmaceutical is classified in the Healthcare sector. On current cash, it currently shows $460B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TAK with unrelated industries.